| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |